Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 1/2 3Phase 1 2

Status

Recruiting 3Withdrawn 2Unknown 2Not yet recruiting 2Completed 2Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Thoracic 1

Conditions

Sarcoma, Ewing 2Small Cell Lung Carcinoma 1Sarcoma 1Neoplasms 1Desmoplastic Small Round Cell Tumor 1

Interventions

pembrolizumab 109Cyclophosphamide 85fludarabine 67Carboplatin 59Injections 58Bevacizumab 52Specimen Handling 42Gemcitabine 41Paclitaxel 40Magnetic Resonance Spectroscopy 40venetoclax 38Nivolumab 38Cisplatin 37Dexamethasone 35Biopsy 34Temozolomide 31Docetaxel 29atezolizumab 27Oxaliplatin 26Capecitabine 26Pemetrexed 25Fluorouracil 25toripalimab 24abemaciclib 24Irinotecan 24Azacitidine 24Fulvestrant 23Rituximab 21fludarabine phosphate 20durvalumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Recruiting × PM 01183 × Clear all
NCT05918640 2026-03-31

LiFFT

Children's Hospital of Philadelphia

Phase 1/2 Recruiting
63 enrolled
Sarcoma

Neoplasms, Sarcoma, Ewing, Desmoplastic Small Round Cell Tumor

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting
166 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05734066 2026-02-03

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Jazz Pharmaceuticals

Phase 1/2 Recruiting
60 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡